Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unilateral involuntary movements of the limbs with caudate nucleus restricted diffusion on magnetic resonance imaging: A case report. | J Int Med Res | 2025 | 40562404 | PubTator, text mining | PubMed |
| Serum Autoantibody Titers and Neurofilament Light Chain Levels in CASPR2/LGI1 Encephalitis: A Longitudinal Study. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40561419 | PubTator, text mining | PubMed |
| Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis. | Ann Clin Transl Neurol | 2025 | 40542589 | PubTator, text mining | PubMed |
| Frequency of synaptic antigen-specific CD4+ T cells in dementia is age-dependent but not correlated with cognitive impairment. | Immun Ageing | 2025 | 40537813 | PubTator, text mining | PubMed |
| Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40537079 | PubTator, text mining | PubMed |
| Case Report: Coexistence of anti-LGI1 and anti-mGluR2 antibodies in an autoimmune encephalitis patient. | Front Immunol | 2025 | 40519939 | PubTator, text mining | PubMed |
| Case Report: Anti-ADAM23 antibody: an overlooked autoantibody against VGKC-complex in autoimmune encephalitis. | Front Immunol | 2025 | 40519920 | PubTator, text mining | PubMed |
| Leucine-rich glioma-inactivated 1 (LGI-1) autoimmune encephalitis presenting as reversible cerebral vasoconstriction syndrome: Initial case report from India. | J Postgrad Med | 2025 | 40488299 | PubTator, text mining | PubMed |
| Gamma-aminobutiric acid-B receptor antibody-related limbic encephalitis due to small cell lung carcinoma: Two case reports. | World J Clin Cases | 2025 | 40487548 | PubTator, text mining | PubMed |
| Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury. | Front Neurol | 2025 | 40470500 | PubTator, text mining | PubMed |
| Clinical Characteristics and Seizure Outcomes in Antibody-Positive Autoimmune Limbic Encephalitis. | J Inflamm Res | 2025 | 40463859 | PubTator, text mining | PubMed |
| Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway. | Brain | 2025 | 40455867 | Swiss-Prot, curated | PubMed |
| Seizure and electroencephalographic characteristics in anti-LGI1 encephalitis. | Clin Neurophysiol | 2025 | 40435857 | PubTator, text mining | PubMed |
| A hierarchy of PDZ domain scaffolding proteins clusters the Kv1 K+ channel protein complex at the axon initial segment. | Sci Adv | 2025 | 40408471 | PubTator, text mining | PubMed |
| Paraneoplastic LGI1 Encephalitis Associated with Lung Adenocarcinoma: A Case Report. | NeuroSci | 2025 | 40407616 | PubTator, text mining | PubMed |
| [Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis diagnosed from T1 signal intensity changes in basal ganglia: a case report and literature review]. | Rinsho Shinkeigaku | 2025 | 40399057 | PubTator, text mining | PubMed |
| Extreme delta brush EEG pattern in anti-LGI1 encephalitis: A case report. | J Neurol Sci | 2025 | 40398375 | PubTator, text mining | PubMed |
| Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II): Antibodies to Surface Antigens. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40393020 | PubTator, text mining | PubMed |
| Beyond the Lab Slip: Why Laboratory Expertise Matters in Neuronal Antibody Testing and Why Clinicians Should Care. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40393019 | PubTator, text mining | PubMed |
| Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study. | CNS Neurosci Ther | 2025 | 40322833 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers?page=11